Streetbeat News

Equity Actions

PHM

PulteGroup, Inc. has announced an increase of $1.5 billion to its share repurchase authorization, signaling confidence in the company's financial stability and a commitment to returning value to shareholders. This move could be seen as a positive sign by investors, as share buybacks often lead to an increase in earnings per share and can boost stock prices in the short term.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 11:26 am

AGFY

I-Tseng Jenny Chan reported a 49.99% stake in Agrify Corporation (AGFY) through a 13D filing on Monday. Following the news, AGFY shares surged 64% in premarket trading.

Portfolio Pulse from Charles Gross

January 30, 2024 | 10:37 am

AAPL

GOOG

META

MSFT

Xreal, a Chinese AR glasses manufacturer, has raised $60 million in funding, surpassing a $1 billion valuation. The company plans to use the funds to expand manufacturing and R&D to meet demand beyond 2024. Xreal is preparing for an IPO within two years and expects revenues of $200-$300 million by 2025. The company competes with Apple, Meta, and Google in the AR market but does not intend to enter the VR space. Xreal captured about 50% of the AR-exclusive device market in Q3 of the previous year.

Portfolio Pulse from Ananya Gairola

January 30, 2024 | 10:36 am

NUTX

Nutex Health has fully paid off its $2.74M debt to Yorkville Advisors and is executing a new strategic plan. This includes closing two underperforming hospitals in Texas, which is expected to save approximately $5 million annually. The company is also working on initiatives to reduce cash operating expenses and improve profitability by the third quarter of fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 10:33 am

VERA

Vera Therapeutics has announced the pricing of an upsized public offering of 8,064,517 shares of Class A common stock at $31 per share, with expected gross proceeds of approximately $250 million. The underwriters have a 30-day option to purchase up to an additional 1,209,677 shares. The offering is set to close on February 1, 2024, pending customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 7:13 am

SIDU

Sidus Space, Inc. (NASDAQ:SIDU) has priced an underwritten public offering of 1,251,700 Class A shares (or Pre-funded Warrants) at $4.50 each, aiming to raise approximately $5.63 million before underwriting discounts and offering expenses. All offered securities are being sold by the Company.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 7:11 am

CNSP

CNS Pharmaceuticals has announced a public offering of 13,333,334 common shares at $0.30 per share, along with Series A and Series B Warrants to purchase an equal number of shares. The warrants are exercisable immediately upon issuance and expire in five years and eighteen months, respectively. The offering is expected to close on or about February 1, 2024, subject to customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 7:05 am

SVM

The NYSE American has approved Silvercorp Metals Inc.'s listing application, which is a significant step forward for the company's proposed acquisition of OreCorp Limited. This approval facilitates the offer by providing Silvercorp with a more prominent platform that could potentially enhance liquidity and investor exposure. The listing on a major U.S. exchange is likely to be viewed positively by investors as it represents a milestone for Silvercorp's growth and expansion strategy.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 6:54 am

DISH

SATS

EchoStar has terminated the exchange offers and consent solicitations for DISH DBS's senior notes. Holders of the Existing DBS Notes who tendered their notes will not receive the exchange consideration and their notes will be returned. This termination does not affect EchoStar's ongoing exchange offers for DISH Network Corporation's convertible notes due in 2025 and 2026.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 6:38 am

NOC

Northrop Grumman has entered into an Accelerated Share Repurchase (ASR) agreement to repurchase $1 billion of its shares. The company anticipates an initial delivery of about 1.8 million shares on January 31, which is roughly 80% of the total expected repurchases under the ASR, based on the closing price of $438.31 on January 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 6:07 am